Copyright
©2014 Baishideng Publishing Group Inc.
World J Cardiol. Aug 26, 2014; 6(8): 814-823
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.814
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.814
Approach | Technique | Device | Study | Follow-up | Outcome |
Invasive | RF ablation | Balloon: | |||
OneShot | Renal hypertension ablation system trial[69] | 12 mo | Average reduction in BP = 30.6 ± 22.0 | ||
Vessix | REDUCE-HTN | Ongoing | |||
Non-balloon: | |||||
Simplicity | SIMPLICITYI[35] | 24 mo | 32/14 | ||
SIMPLICITYII[62] | 6 mo | 32/12 | |||
SIMPLICITYIII | Ongoing trial | ||||
Spiral | Renal hypertension ablation system trial[69] | 12 mo | Average reduction in BP = 30.6 ± 22.0 | ||
EnligHTN | EnligHTN I trial[70] | 6 mo | Reduction in BP-26/10 | ||
Ultrasound | Paradise | REALISE[71] | 3 mo | Reduction in BP 22/12 | |
TIVUS | TIVUS I | Ongoing study | |||
Non-invasive | Ultrasound | Verve | |||
Chemical | Cisplatin | Salman[72] | Animal study | ||
Vincristine | Silva | Animal study | |||
Guanethidine | Koistinaho[73] | Animal study | |||
Neurotoxin | Apex nano nanomagnetic therapy | Animal studies | |||
Other | Beta radiation cath | Novoste[74] |
- Citation: Kannan A, Medina RI, Nagajothi N, Balamuthusamy S. Renal sympathetic nervous system and the effects of denervation on renal arteries. World J Cardiol 2014; 6(8): 814-823
- URL: https://www.wjgnet.com/1949-8462/full/v6/i8/814.htm
- DOI: https://dx.doi.org/10.4330/wjc.v6.i8.814